Evidence map›Paper›PMID 39999317›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

NIR-II Emissive Persistent Neutral π-Radical with Rapid Doublet Internal Conversion for Efficient Cancer Photothermal Theranostics.

Qi Zhao, Chunxiao Wu, Yijian Gao, Jing Long, Wei Zhang, Yanan Chen, Yuliang Yang, Yu Luo, Yuxiao Lai, Houyu Zhang and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qi ZhaoCollege of Pharmaceutical Sciences, The Fourth Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, 215123, P. R. China.
Chunxiao WuState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Qianjin Avenue 2699, Changchun, 130012, P. R. China.
Yijian GaoCollege of Pharmaceutical Sciences, The Fourth Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, 215123, P. R. China.
Jing LongCentre for Translational Medicine Research & Development, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China.
Wei ZhangCentre for Translational Medicine Research & Development, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China.
Yanan ChenState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Qianjin Avenue 2699, Changchun, 130012, P. R. China.
Yuliang YangCollege of Pharmaceutical Sciences, The Fourth Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, 215123, P. R. China.
Yu LuoCollege of Pharmaceutical Sciences, The Fourth Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, 215123, P. R. China.
Yuxiao LaiCentre for Translational Medicine Research & Development, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, P. R. China.
Houyu ZhangState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Qianjin Avenue 2699, Changchun, 130012, P. R. China.
Xiankai ChenInstitute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, 215123, P. R. China.
Feng LiState Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Qianjin Avenue 2699, Changchun, 130012, P. R. China.
Shengliang LiCollege of Pharmaceutical Sciences, The Fourth Affiliated Hospital of Soochow University, Suzhou Medical College, Soochow University, Suzhou, 215123, P. R. China.ORCID https://orcid.org/0000-0002-3890-8482

Funding

Leading Talents of Innovation and Entrepreneurship of Gusu ZXL2022496National Natural Science Foundation of China 22007098National Natural Science Foundation of China 22207024National Natural Science Foundation of China 51925303National Natural Science Foundation of China 52173135National Natural Science Foundation of China 82022045Natural Science Foundation of Jiangsu Province BK20231523Priority Academic Program Development (PAPD) of Jiangsu Higher Education InstitutionsSuzhou International Joint Laboratory for Diagnosis and Treatment of Brain DiseasesSuzhou Science and Technology Program SKY2022039
6 · The paper itself

Abstract

Organic radicals are considered prospective materials for near-infrared (NIR) photothermal applications, however, sustainability remains the major obstacle of recently reported ionic radical photothermal agents. This work achieved robust sustainability on a series of neutral π-radicals through rational design donor (D)-acceptor (A). With efficient doublet internal conversion, 10H-spiro(acridine-9,9'-fluorene) (SFA)-BTM presented strong NIR absorption extended to 1000 nm and efficient non-radiative relaxation. SFA-BTM nanoparticles (NPs) realized comparable NIR-I photothermal conversion efficiency (PCE) and photoacoustic sensitivity. Also, the π-radical NPs displayed NIR-II emission and achieved high-resolution whole-body angiography for the first time by the NIR-II bioimaging. Ultimately, the photothermal capabilities are confirmed in an orthotopic bone tumor model by effective ablation of cancer cells in vitro and inhibition of the deterioration of tumor in vivo. This research offers a new horizon in the conception and development of sustainable organic radicals for effective NIR-II imaging and theranostics applications.

Indexed as

NeoplasmsPhototherapyPhotothermal TherapyTheranostic NanomedicineAnimalsCell Line, TumorHumansInfrared RaysMiceNanoparticlesconjugated oligomerNIR‐IIphotoacoustic imagingphotothermal therapyradical

Identifiers

PMID39999317
PMCPMC12005734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.